629 research outputs found
Why Not? Explaining Missing Entailments with Evee (Technical Report)
Understanding logical entailments derived by a description logic reasoner is
not always straight-forward for ontology users. For this reason, various
methods for explaining entailments using justifications and proofs have been
developed and implemented as plug-ins for the ontology editor Prot\'eg\'e.
However, when the user expects a missing consequence to hold, it is equally
important to explain why it does not follow from the ontology. In this paper,
we describe a new version of , a Prot\'eg\'e plugin
that now also provides explanations for missing consequences, via existing and
new techniques based on abduction and counterexamples
Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis
The structure of the human major histocompatability (MHC) class I molecule HLA-A*0301 (HLA-A3) in complex with a nonameric peptide (KLIETYFSK) has been determined by X-ray crystallography to 2.7 Å resolution. HLA-A3 is a predisposing allele for multiple sclerosis (MS), an autoimmune disease of the central nervous system. The KLIETYFSK peptide is a naturally processed epitope of proteolipid protein, a myelin protein and candidate target for immune-mediated myelin destruction in MS. Comparison of the structure of HLA-A3 with that of HLA-A2, an MHC class I molecule which is protective against MS, indicates that both MHC class I molecules present very similar faces for T-cell receptor recognition whilst differing in the specificity of their peptide-binding grooves. These characteristics may underlie the opposing (predisposing versus protective) associations that they exhibit both in humans and in mouse models of MS-like disease. Furthermore, subtle alterations within the peptide-binding groove of HLA-A3 and other A3-like MHC class I molecules, members of the so-called A3 superfamily, may be sufficient to alter their presentation of autoantigen peptides such as KLIETYFSK. This in turn may modulate their contribution to the associated risk of autoimmune disease
Процесс фтороаммонийной переработки высокофтористых бериллиевых концентратов
В работе приведено научное обоснование способа фтороаммонийной переработки высокофтористого бериллиевого концентрата, предложены технологические режимы переработки бериллиевого концентрата. Исследование технологического процесса и определение режимов, обеспечивающих экономически эффективную переработку концентратов, проводили на специально изготовленной опытной установке. В результате работы создана и апробирована принципиальная схема переработки бериллиевых концентратов, разработано аппаратурное оформление процесса. Приведено технико-экономическое обоснование технологии.The scientific substantiation of the processing of high-fluoride beryllium concentrates by ammonium fluoride is given in graduation thesis. Technological conditions of beryllium concentrate processing are proposed. The research of the technological process and determination of the conditions providing cost-effective processing of concentrates was carried out on a specially manufactured pilot plant. As a result of the work, a basic scheme for the processing of beryllium concentrates was developed and approved, and the hardware design of the process was developed. The feasibility study of technology is shown
Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)
Every 2 years, the International Consensus Conference on the Treatment of Primary Breast Cancer takes place in St. Gallen. Given that the concept of the St. Gallen Consensus Conference mainly reflects an international opinion, it appears useful to adapt the results of the vote for everyday therapy in Germany. A German working group comprising 28 breast cancer experts, amongst whom there are 3 members of the international St. Gallen panel, has therefore commented on this year's St. Gallen Consensus Conference (2011) from the German viewpoint. The focus of interest of this year's St. Gallen Conference was tumour biology as the starting point for decisions regarding individual therapy. There was an intensive discussion in relation to the clinical relevance of predictive and prognostic factors and possible consequences for decisions regarding therapy. Therefore, questions concerning the indication for adjuvant chemotherapy focused especially on the significance of the molecular phenotype of the tumour. In addition, important points for discussion were also the value of complete axillary dissection and the use of accelerated complete breast irradiation
Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer-Evaluation of Several Markers with Real-Time Reverse Transcription-PCR
It is widely known that cells from epithelial tumors, e. g., breast cancer, detach from their primary tissue and enter blood circulation. We show that the presence of circulating tumor cells (CTCs) in samples of patients with primary and metastatic breast cancer can be detected with an array of selected tumor-marker-genes by reverse transcription real-time PCR. The focus of the presented work is on detecting differences in gene expression between healthy individuals and adjuvant and metastatic breast cancer patients, not an accurate quantification of these differences. Therefore, total RNA was isolated from blood samples of healthy donors and patients with primary or metastatic breast cancer after enrichment of mononuclear cells by density gradient centrifugation. After reverse transcription real-time PCR was carried out with a set of marker genes (BCSP, CK8, Her2, MGL, CK18, CK19). B2M and GAPDH were used as reference genes. Blood samples from patients with metastatic disease revealed increased cytokine gene levels in comparison to normal blood samples. Detection of a single gene was not sufficient to detect CTCs by reverse transcription real-time PCR. Markers used here were selected based on a recent study detecting cancer cells on different protein levels. The combination of such a marker array leads to higher and more specific discovery rates, predominantly in metastatic patients. Identification of CTCs by PCR methods may lead to better diagnosis and prognosis and could help to choose an adequate therapy
T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder
While a link between inflammation and the development of neuropsychiatric
disorders, including major depressive disorder (MDD) is supported by a growing
body of evidence, little is known about the contribution of aberrant adaptive
immunity in this context. Here, we conducted in-depth characterization of T
cell phenotype and T cell receptor (TCR) repertoire in MDD. For this cross-
sectional case–control study, we recruited antidepressant-free patients with
MDD without any somatic or psychiatric comorbidities (n = 20), who were
individually matched for sex, age, body mass index, and smoking status to a
non-depressed control subject (n = 20). T cell phenotype and repertoire were
interrogated using a combination of flow cytometry, gene expression analysis,
and next generation sequencing. T cells from MDD patients showed significantly
lower surface expression of the chemokine receptors CXCR3 and CCR6, which are
known to be central to T cell differentiation and trafficking. In addition, we
observed a shift within the CD4+ T cell compartment characterized by a higher
frequency of CD4+CD25highCD127low/− cells and higher FOXP3 mRNA expression in
purified CD4+ T cells obtained from patients with MDD. Finally, flow
cytometry-based TCR Vβ repertoire analysis indicated a less diverse CD4+ T
cell repertoire in MDD, which was corroborated by next generation sequencing
of the TCR β chain CDR3 region. Overall, these results suggest that T cell
phenotype and TCR utilization are skewed on several levels in patients with
MDD. Our study identifies putative cellular and molecular signatures of
dysregulated adaptive immunity and reinforces the notion that T cells are a
pathophysiologically relevant cell population in this disorder
Study of exclusive one-pion and one-eta production using hadron and dielectron channels in pp reactions at kinetic beam energies of 1.25 GeV and 2.2 GeV with HADES
We present measurements of exclusive ensuremathπ+,0 and η production in pp reactions at 1.25GeV and 2.2GeV beam kinetic energy in hadron and dielectron channels. In the case of π+ and π0 , high-statistics invariant-mass and angular distributions are obtained within the HADES acceptance as well as acceptance-corrected distributions, which are compared to a resonance model. The sensitivity of the data to the yield and production angular distribution of Δ (1232) and higher-lying baryon resonances is shown, and an improved parameterization is proposed. The extracted cross-sections are of special interest in the case of pp → pp η , since controversial data exist at 2.0GeV; we find \ensuremathσ=0.142±0.022 mb. Using the dielectron channels, the π0 and η Dalitz decay signals are reconstructed with yields fully consistent with the hadronic channels. The electron invariant masses and acceptance-corrected helicity angle distributions are found in good agreement with model predictions
A2A adenosine receptor-driven cAMP signaling in olfactory bulb astrocytes is unaffected in experimental autoimmune encephalomyelitis
IntroductionThe cyclic nucleotide cyclic adenosine monophosphate (cAMP) is a ubiquitous second messenger, which is known to play an important anti-inflammatory role. Astrocytes in the central nervous system (CNS) can modulate inflammation but little is known about the significance of cAMP in their function.MethodsWe investigated cAMP dynamics in mouse olfactory bulb astrocytes in brain slices prepared from healthy and experimental autoimmune encephalomyelitis (EAE) mice.ResultsThe purinergic receptor ligands adenosine and adenosine triphosphate (ATP) both induced transient increases in cAMP in astrocytes expressing the genetically encoded cAMP sensor Flamindo2. The A2A receptor antagonist ZM241385 inhibited the responses. Similar transient increases in astrocytic cAMP occurred when olfactory receptor neurons were stimulated electrically, resulting in ATP release from the stimulated axons that increased cAMP, again via A2A receptors. Notably, A2A-mediated responses to ATP and adenosine were not different in EAE mice as compared to healthy mice.DiscussionOur results indicate that ATP, synaptically released by afferent axons in the olfactory bulb, is degraded to adenosine that acts on A2A receptors in astrocytes, thereby increasing the cytosolic cAMP concentration. However, this pathway is not altered in the olfactory bulb of EAE mice
Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis
- …